ICG's pharma media agency plans and buys media where Indian HCPs actually consume content — LinkedIn, closed HCP communities, CME platforms, programmatic on HCP-only inventory, and selected industry publications. Built by IIT BHU pharmaceutical engineers. Compliance-safe. Audience-precise. Measured against prescription outcomes — not impressions.
The campaign delivered 10M impressions. How many of those impressions reached your prescribing HCPs? Most pharma teams cannot answer that.
Pharma media buying gets gamed by impression-volume metrics. The real question — did the media reach actual prescribing HCPs in your therapeutic area? — is rarely answered with precision. ICG's pharma media practice starts with the HCP audience definition (specialty, geography, prescription behaviour where data exists) and works backward to the inventory that actually reaches them. Smaller volume. Better audience. Measurable impact on prescription patterns.
LinkedIn Sales Navigator + targeted ads against HCPs by specialty, seniority, geography. The single most precise HCP digital channel in India.
Sponsorship and content placement on Indian HCP-only platforms — Practo, Medibrains, DocMode, and CME networks.
Programmatic via SSPs that serve HCP-verified inventory only. No consumer leakage.
Print and digital placement in Express Pharma, Pharmabiz, Voice of Healthcare, and specialty-specific publications.
Congress sponsorship strategy, booth media, satellite symposium media. Tied to congress lead-capture outcomes.
HCP-level reach measurement (where data permits), prescription outcome attribution via Pharos RxFlow, ongoing campaign optimisation.
ICG's Co-Founding Team and pharma practice lead are pharmaceutical engineers from IIT BHU's Department of Pharmaceutical Engineering and Technology — B.Tech and M.Tech graduates who have studied drug metabolism, formulation science, pharmacokinetics, and clinical pharmacology.
This is not a credential for a website. It is the reason why ICG manuscripts have fewer scientific errors in medical review, why ICG PSURs have fewer clarification cycles, and why the scoping call for a literature monitoring engagement sounds different from every other agency you've briefed. The science is understood before the brief is written.
ICG's commercial and field force engagements run on RxFlow, RouteIQ, Gate, Signal, and Pulse — five tools that connect field activity to prescription outcomes.
Explore the full Pharos platform →AI Scientific Writing
AI-guided manuscript development from topic selection to submission-ready output. Journal fit intelligence. CONSORT/PRISMA embedded from Day 1.
Literature Monitoring
Adverse-event-driven literature surveillance. Validated PubMed queries. De-duplication. Evidence scoring. Audit-ready search logs.
PV Resource Allocation
Risk-based drug tiering and defensible PV staffing. Objective tier from signal frequency and seriousness. Headcount you can defend with data.
Drug AE Intelligence
Single-drug adverse event visualization dashboard. On-demand data refresh. Spot signals before they escalate.
Prescription Intelligence
HCP-level prescription intelligence. Visit history, AI call analysis. See Rx switching risk before it moves.
Explore RxFlow →MR Route Optimization
AI route planning for medical representatives. Priority-scored daily call plans. Right HCP, right day, every day.
Explore RouteIQ →Sales Pipeline Intelligence
Stagnation alerts before deals go cold. Stage bottleneck heatmaps. Intervene before it's too late.
Explore Gate →MR AI Coaching
AI coaching after every HCP visit. Post-visit feedback, objection analysis. Turn each visit into a prescription.
Explore Signal →Pharma MIS Command Centre
360° commercial intelligence for leadership. Revenue, field force, distributor, market — one real-time view.
Explore Pulse →Every ICG pharma engagement runs on some combination of these nine modules. The pilot engagement determines which ones are active from Day 1.
Start a pilot project →Every ICG pharma engagement is led personally by Aditi Tripathi — M.Pharm, IIT BHU — with Abhash, Deep and Rohit (Co-Founding Team) bringing the scientific rigour, delivery architecture and commercial lens built across 8+ years. IIT BHU pharmaceutical engineers at every level of the engagement.
60+ specialists. One process. Every deliverable in-house. Gurgaon, since 2018.
Strategy Lead · IIT BHU + IIM Bangalore
Leads scientific strategy and quality governance. Sets the standard for scientific rigour across every engagement.
Profile →
Operations Lead · IIT BHU (B.Tech + M.Tech)
Owns the AI-powered delivery system — the multi-tenant operations layer that runs every pharma engagement on time and on spec.
Profile →
Business & Growth Lead · IIT BHU + IIM Rohtak
Pharma engineer who owns business growth and the commercial lens connecting science to prescription outcomes.
Profile →
IIT BHU · M.Pharm
Aditi leads every pharma engagement end to end — from scoping the scientific writing architecture to governing quality across delivery. Her M.Pharm from IIT BHU means she doesn't need the science explained to her. "She explains it to everyone else."
One deliverable. Full ICG process. Audit trail. Then you decide.
A founder will reach out within one business day. In the meantime — WhatsApp Rohit directly for the fastest reply.
💬 Message Rohit on WhatsApp
For pharma / life sciences — medical writing, scientific communications, regulatory support — I reply personally.
Message Rohit on WhatsAppOr call: +91 81302 26224